Negative Pressure Wound Therapy (PREVENA) Versus Standard Dressings for Incision Management After Renal Transplant

Last updated: May 9, 2019
Sponsor: Royal North Shore Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT03948412
RNSH-VASC-2019-1
  • Ages > 18
  • All Genders

Study Summary

This study is a multicentre, partially-blinded randomised controlled trial, with site stratified block randomisation and partial blinding of outcome assessments. Patients undergoing a renal transplant will be allocated to one of two treatment arms, where either a Prevena device of appropriate size or standard dressing is applied to the closed incision. In the case that a patient requires bilateral incisions, both incisions will be allocated to the same treatment arm and counted as a single incision.

Primary:

The primary objective of this study is to determine if the Prevena Incision Management System reduces wound complications at the surgical site following renal transplant, when compared to standard dressings. Secondary: Secondary objectives of this study include identification of risk factors for wound complications at the surgical site, as well as re-operation, prolonged hospital stay, allograft survival, delayed graft function. This study will also assess pain, scar healing and quality of life in each treatment arm, and aim to complete a cost-benefit analysis of the Prevena device in renal transplantation.

Eligibility Criteria

Inclusion

Inclusion Criteria: The participant:

  1. is an adult ≥ 18 years old, regardless of comorbidities or BMI

  2. is able to provide their own informed consent

  3. will undergo open renal transplant surgery, including those who undergo dual renaltransplant or simultaneous pancreas transplant.

  4. will require a surgical incision(s) likely to be able to be covered completely by oneor more Prevena Incision Management Systems.

  5. is willing and able to return for the required follow up assessments.

  6. if concurrently enrolled in a clinical trial it must not impact on patient health orthe surgical incision site and the study must be documented

Exclusion

Exclusion Criteria: The participant:

  1. has a known allergy or hypersensitivity to silver, or drape materials that containacrylic adhesives.

  2. Is not suitable for closure of the surgical wound, and as such the wound must be leftopen or an open NPWT device is required.

  3. Is not willing to comply with the study procedures.

  4. Has an unforseen intraoperative event mandating additional management including aplanned re-exploration.

  5. Has obvious intraoperative contamination of the surgical site.

  6. Has a wound with suspected ischaemia in the incision area, or inadequate haemostasis.

  7. Requires drains that cannot be covered by the Prevena dressing.

Study Design

Total Participants: 500
Study Start date:
May 10, 2019
Estimated Completion Date:
September 30, 2021

Connect with a study center

  • Royal North Shore Hospital

    Sydney, New South Wales 2065
    Australia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.